The presence of depression in schizophrenia has been a challenge to the Kraepelinian dichotomy, with various attempts to save the fundamental distinction including evoking and refining diagnoses such as schizoaffective disorder. But the tectonic plates are shifting. Here we put forward a summary of recent evidence regarding the prevalence, importance, possible aetiological pathways and treatment challenges that recognising depression in schizophrenia bring. Taken together we propose that depression is more than co-morbidity and that increased effective therapeutic attention to mood symptoms will be needed to improve outcomes and to support prevention
The interplay of psychotic and affective symptoms is a crucial challenge in understanding the pathog...
On the basis of data derived from a long-term follow-up of 12 cases and a 2-year follow-up of the In...
The symptoms of schizophrenia involve positive symptoms (delusions and hallucinations), negative sym...
The presence of depression in schizophrenia has been a challenge to the Kraepelinian dichotomy, with...
© 2021 Sarah Elizabeth HernimanIt is unclear whether the depression experienced by individuals with ...
There has been renewed interest into affective symptoms and psychological approaches to schizophreni...
Psychosis and depression are syndromes that affect the most basic human processes of perception and ...
Schizophrenia, characterised by psychotic symptoms and in many cases social and occupational decline...
Objective: There is a need to better understand the interrelationships between positive and negative...
Despite the increasingly widespread availability of psychotropics believed to restore biochemical eq...
International audienceBackground Major Depressive Disorder (MDD) is a therapeutic challenge in schiz...
Depression frequently occurs in first-episode psychosis (FEP) and predicts longer-term negative outc...
Abstract Depressive disorder prevalence in patients with schizophrenia has been reported to be 40%. ...
The neurodevelopmental vulnerability for schizophrenia appears to be expressed across a dynamic cont...
Background: It is commonly assumed that there are clear lines of demarcation between anxiety and dep...
The interplay of psychotic and affective symptoms is a crucial challenge in understanding the pathog...
On the basis of data derived from a long-term follow-up of 12 cases and a 2-year follow-up of the In...
The symptoms of schizophrenia involve positive symptoms (delusions and hallucinations), negative sym...
The presence of depression in schizophrenia has been a challenge to the Kraepelinian dichotomy, with...
© 2021 Sarah Elizabeth HernimanIt is unclear whether the depression experienced by individuals with ...
There has been renewed interest into affective symptoms and psychological approaches to schizophreni...
Psychosis and depression are syndromes that affect the most basic human processes of perception and ...
Schizophrenia, characterised by psychotic symptoms and in many cases social and occupational decline...
Objective: There is a need to better understand the interrelationships between positive and negative...
Despite the increasingly widespread availability of psychotropics believed to restore biochemical eq...
International audienceBackground Major Depressive Disorder (MDD) is a therapeutic challenge in schiz...
Depression frequently occurs in first-episode psychosis (FEP) and predicts longer-term negative outc...
Abstract Depressive disorder prevalence in patients with schizophrenia has been reported to be 40%. ...
The neurodevelopmental vulnerability for schizophrenia appears to be expressed across a dynamic cont...
Background: It is commonly assumed that there are clear lines of demarcation between anxiety and dep...
The interplay of psychotic and affective symptoms is a crucial challenge in understanding the pathog...
On the basis of data derived from a long-term follow-up of 12 cases and a 2-year follow-up of the In...
The symptoms of schizophrenia involve positive symptoms (delusions and hallucinations), negative sym...